{"acute graft versus host disease": 12.09, "acute graft versus host disease in skin": 38.79, "acute lymphocytic leukaemia": 157.51, "acute lymphocytic leukaemia recurrent": 959.88, "acute lymphocytic leukaemia refractory": 1043.62, "alanine aminotransferase increased": 2.63, "altered state of consciousness": 4.87, "aphasia": 9.66, "aspartate aminotransferase increased": 2.81, "ataxia": 2.67, "b precursor type acute leukaemia": 779.65, "b-cell type acute leukaemia": 252.68, "bacteraemia": 8.85, "blast cell count increased": 477.78, "blood bilirubin increased": 3.25, "blood immunoglobulin g decreased": 29.56, "blood lactate dehydrogenase increased": 3.45, "bone marrow failure": 5.07, "c-reactive protein increased": 3.57, "central nervous system leukaemia": 1341.08, "confusional state": 3.3, "csf cell count increased": 148.24, "cytokine release syndrome": 250.64, "cytomegalovirus infection": 5.56, "cytopenia": 4.42, "delirium": 5.21, "depressed level of consciousness": 2.09, "device related infection": 31.48, "disease progression": 2.85, "disease recurrence": 6.29, "disorientation": 4.32, "disseminated intravascular coagulation": 9.51, "dysgraphia": 18.88, "encephalopathy": 11.17, "febrile neutropenia": 8.85, "full blood count abnormal": 3.01, "generalised tonic-clonic seizure": 3.68, "graft versus host disease": 19.06, "graft versus host disease in gastrointestinal tract": 59.01, "graft versus host disease in skin": 58.77, "haemophagocytic lymphohistiocytosis": 7.05, "hepatotoxicity": 7.95, "hyperbilirubinaemia": 2.87, "hypogammaglobulinaemia": 38.98, "hypoxia": 2.58, "immune effector cell-associated neurotoxicity syndrome": 22.25, "immunoglobulins decreased": 44.34, "incorrect drug administration rate": 21.99, "infection": 4.44, "infusion site haemorrhage": 109.69, "injection site haemorrhage": 10.33, "leukaemia recurrent": 24.46, "leukaemic infiltration extramedullary": 3794.07, "leukoencephalopathy": 11.54, "liver disorder": 2.33, "liver function test increased": 2.74, "lymphocyte count decreased": 4.9, "mental status changes": 6.99, "minimal residual disease": 170.36, "multiple organ dysfunction syndrome": 2.6, "myelosuppression": 2.28, "nervous system disorder": 12.89, "neurological symptom": 25.07, "neurotoxicity": 148.15, "neutropenia": 4.91, "neutrophil count decreased": 9.49, "off label use": 2.61, "pancytopenia": 4.67, "platelet count decreased": 3.76, "pneumocystis jirovecii pneumonia": 4.96, "pyrexia": 2.05, "seizure": 4.31, "sepsis": 4.37, "septic shock": 4.06, "speech disorder": 2.13, "status epilepticus": 4.56, "therapeutic product effect incomplete": 2.37, "therapy non-responder": 12.79, "thrombosis in device": 25.13, "transaminases increased": 2.01, "tremor": 3.58, "tumour lysis syndrome": 35.26, "unevaluable event": 3.19, "vascular device infection": 12.28, "venoocclusive disease": 31.27, "venoocclusive liver disease": 19.41, "white blood cell count abnormal": 12.96, "white blood cell count decreased": 2.75, "white blood cell count increased": 6.13}